Paratek Pharmaceuticals, Inc. announced in accordance with the Merger Agreement, at the Effective Time, each of the directors of the company (Minnie V. Baylor-Henry, Michael F. Bigham, Evan Loh, M.D., Thomas J. Dietz, Ph.D., Timothy R. Franson, M.D., Rolf K. Hoffman, Kristine Peterson, Robert S. Radie and Jeffrey Stein, Ph.D.) resigned as directors of the company. These resignations were in connection with the Merger and not as a result of any disagreements between the company and the resigning individuals on any matters related to the company?s operations, policies or practices. As of the Effective Time, in accordance with the Merger Agreement, Stacy Seltzer and Adam Dilluvio, the directors of Merger Sub immediately prior to the Effective Time, became directors of the company.